ANI Pharmaceuticals Financials
| BSFA Stock | 54.00 1.50 2.70% |
ANI |
Understanding current and past ANI Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ANI Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in ANI Pharmaceuticals' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in ANI Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ANI Pharmaceuticals. Check ANI Pharmaceuticals' Beneish M Score to see the likelihood of ANI Pharmaceuticals' management manipulating its earnings.
| Foreign Associate | Germany |
| Instrument | Germany Stock View All |
| Exchange | Stuttgart Exchange |
| ISIN | US00182C1036 |
| Business Address | 210 Main Street |
| Sector | Healthcare |
| Industry | Drug Manufacturers-Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.anipharmaceuticals.com |
| Phone | 218 634 3500 |
You should never invest in ANI Pharmaceuticals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of ANI Stock, because this is throwing your money away. Analyzing the key information contained in ANI Pharmaceuticals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
ANI Pharmaceuticals Key Financial Ratios
ANI Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from ANI Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of ANI Pharmaceuticals over time and compare it to other companies across industries.| Return On Equity | -0.26 | |||
| Return On Asset | -0.0374 | |||
| Number Of Employees | 601 | |||
| Beta | 1.06 | |||
| Z Score | 1.2 |
ANI Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ANI Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare ANI Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ANI Pharmaceuticals competition to find correlations between indicators driving ANI Pharmaceuticals's intrinsic value. More Info.ANI Pharmaceuticals is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ANI Pharmaceuticals' earnings, one of the primary drivers of an investment's value.ANI Pharmaceuticals Systematic Risk
ANI Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ANI Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Beta measures systematic risk based on how returns on ANI Pharmaceuticals correlated with the market. If Beta is less than 0 ANI Pharmaceuticals generally moves in the opposite direction as compared to the market. If ANI Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ANI Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ANI Pharmaceuticals is generally in the same direction as the market. If Beta > 1 ANI Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
ANI Pharmaceuticals December 3, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of ANI Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ANI Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of ANI Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing ANI Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ANI Pharmaceuticals's daily price indicators and compare them against related drivers.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 13.42 | |||
| Value At Risk | (3.70) | |||
| Potential Upside | 3.81 |
Additional Tools for ANI Stock Analysis
When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.